Table 6.

Clinical response and clinical remission ^* at week 6-comparison between the one-to-one matched cohorts from this study and the open-label sub-cohort of GEMINI 1 study.

Outcomes	Comparative cohorts		Odds ratio (95% CI) and p-value
	Korean study; matched subjects (n = 47)	GEMINI 1 study; matched subjects from the open-label, anti-TNF failure cohort (n = 47)
Week 6 clinical response rate – n (%)	24 (51.1)	12 (25.5)	3.01 (1.18–8.02); p = 0.019
Week 6 clinical remission rate – n (%)	7 (14.9)	9 (19.1)	0.74 (0.21–2.49); p = 0.785

^*Please see the Supplemental Table for a summary of definitions for clinical response and remission used in the GEMINI 1 study versus this observational study.

CI, confidence interval; TNF, tumor necrosis factor.